Skip to content

Total Hip Femoral Component

by Advanced Biosearch Assn.

510(k) K840150

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK840150 Date27 Feb 1984ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
JDI
Device Class
Class II
Regulation
21 CFR Part 888.3350
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 26 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

A total hip femoral component is a device intended to be implanted to replace a hip joint. It limits translation and rotation in one or more planes via the geometry of its articulating surfaces and has no linkage across the joint.

This device is a Class 2 Orthopedic device with product code JDI, cleared through the Traditional 510(k) pathway. It was manufactured by Advanced Biosearch Assn. and received FDA 510(k) clearance under K840150 on February 27, 1984.

Other devices from Advanced Biosearch Assn.

See all devices from Advanced Biosearch Assn. →

Questions

AI-generated answers, 26 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the TOTAL HIP FEMORAL COMPONENT used for?

    It is implanted to replace a hip joint, limiting translation and rotation in one or more planes through the geometry of its articulating surfaces, with no linkage across the joint, to restore joint stability and function.

  • How is the TOTAL HIP FEMORAL COMPONENT supplied and what is its regulatory pathway?

    It is supplied as a sterile, single-use implant for surgical implantation and was cleared through the FDA Traditional 510(k) pathway under K840150, demonstrating substantial equivalence to a predicate device.

  • What classification and product code does the TOTAL HIP FEMORAL COMPONENT have?

    It is classified as a Class 2 orthopedic device with product code JDI, as indicated in its FDA 510(k) clearance documentation, which determines its regulatory controls and post-market requirements.